Brain penetration and neurological effects of gadobenate dimeglumine in the rat

Acta Radiologica

Volumn 38, Issue 2, 1997, Pages 268-272

  Luzzani, Franco ^a   Cipolla, P ^a   Pelaprat M L ^b   Robert, F ^b   Gotti, C ^b   Tirone, P ^a   De Haen C ^a  

^a Bracco SpA   (Italy)

^b Bracco Suisse SA   (Switzerland)

Author keywords

Brain blood barrier, MR; Experimental; Gadolinium

Indexed keywords

CONTRAST MEDIUM; DRUG DERIVATIVE; GADOBENIC ACID; MEGLUMINE; ORGANOMETALLIC COMPOUND;

ANIMAL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; COMPARATIVE STUDY; DRUG EFFECT; INTRASPINAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CONTRAST MEDIA; INJECTIONS, INTRAVENOUS; INJECTIONS, SPINAL; MALE; MEGLUMINE; MOTOR ACTIVITY; ORGANOMETALLIC COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031085011     PISSN: 02841851     EISSN: None     Source Type: Journal    
DOI: 10.3109/02841859709172061     Document Type: Article

References (26)

1. CAVAGNA D., MAGGIONI F., CASTELLI P. M., VICINANZA E., MARZOLA P. & DAPRÀ M.: Weak binding of Gd-BOPTA/dimeg to extravasated serum protein enhances conspicuity of brain tumors in rats. Radiology 193 (P) (1994), 210.
2. DAVIES A. & DE HAËN C.: Gadobenic acid dimeglumine salt. Drugs Fut. 16 (1991), 1001.
3. DUNHAM N. W. & MIYA T. S.: A note on a simple apparatus for detecting neurological deficit in rats and mice. J. Am. Pharm. Assoc. 46 (1957), 208.
4. FELDER E., UGGERI F., FUMAGALLI L., VITTADINI G. (Bracco Industria Chimica SpA, Milan, Italy): Paramagnetic chelates useful for NMR imaging. U.S. Patent 4,916,246 (CO7F13/00; 556/1) 10 April, 1990, IT 19236A/86, 30 January, 1986.
5. GALLUCCI M., APRILE I., CARDONE G. P., DI RENZI P., MIGLIORI O. & PASSARIELLO R.: Diagnostic value of Gd-BOPTA, a new contrast agent for the study of intracranial tumors. Preliminary results in comparison with Gd-DTPA. Neuroradiology 34 (Suppl.) (1992), 31.
6. JEFFERS W. A. & GRIFFITH J. Q. (also editors): The rat in laboratory investigation, p. 196. Lippincott. Philadelphia 1949.
7. JOHANSSON B. B.: Hypertension and the blood-brain barrier. In : Implications of the blood-brain barrier and its manipulation, vol. 2, p. 389. Edited by E. A. Neuwelt. Plenum Press, New York 1989.
8. LARSSON H., STUBGAARD M., FREDRIKSEN J., JENSEN M., HENRIKSEN O. & PAULSON O.: Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn. Reson. Med. 16 (1990), 117.
9. MAGGIONI F., CASTELLI P. M., MARZOLA P. et al.: Magnetization transfer MR imaging of experimental rat brain tumors with Gd-BOPTA/dimeglumine and Gd-DTPA/dimeglumine. Radiology 197(P) (1995), 149.
10. E. MERCK: Complexometric assay methods with Titriplex®. E. Merck, Darmstadt, Germany 1982.
11. MERLIS J. K.: The effects of changes in the calcium content of the cerebrospinal fluid on spinal reflex activity in the dog. Am. J. Physiol. 13 (1940) 71.
12. O'BRIEN M. D., JORDAN M. M. & WALTZ A. G.: Ischemic cerebral edema and the blood brain barrier. Distributions of pertechnetate, albumin, sodium, and antipyrine in brains of cats after occlusion of the middle cerebral artery. Arch. Neurol. 30 (1974), 461.
13. PETITO C. K. & CASH K. S.: Blood brain abnormalities in the acquired immunodeficiency syndrome. Immunohistochemical localization of serum proteins in postmortem brain. Ann. Neurol. 32 (1992), 658.
14. PIROVANO G., LORUSSO V., TIRONE P. & ROSATI G.: Tolerance and pharmacokinetic evaluation of Gd-BOPTA/dimeg at high doses in healthy volunteers. J. Magn. Reson. Imaging 3 (P) (1993), 155.
15. PRESTON E., ALLEN M. & HAAS N.: A modified method for measurement of radiotracer permeation across the rat blood-brain barrier. The problem of correcting brain uptake for intravascular tracer. J. Neurosci. Meth. 9 (1983), 45.
16. PRESTON E., BUTLER K. & HAAS N.: Does magnetic resonance imaging compromise integrity of the blood-brain barrier? Neurosci. Lett. 101 (1989), 46.
17. RAPOPORT S. I.: Sites and functions of the blood-brain barrier. In: Blood-brain barrier in physiology and medicine, chapter 3, p. 43. Raven Press, New York 1976.
18. RAPOPORT S. I. & THOMSON H. K.: Osmotic opening of the blood-brain barrier in the monkey without associated neurological deficits. Science 180 (1973), 971.
19. ROMAN-GOLDSTEIN S., CLUNIE D. A., STEVENS J. et al.: Osmotic blood-brain barrier disruption. CT and radionuclide imaging. AJNR 15 (1994), 581.
20. ROSATI G., PIROVANO G. & SPINAZZI A.: Interim results of phase II clinical testing of gadobenate dimeglumine (Gadobenate). Invest. Radiol. 29 (Suppl. 2) (1994), S183.
21. SCHMIEDL U. P., KENNEY J. & MARAVILLA K. R.: Kinetics of pathologic blood-brain barrier permeability in an astrocytic glioma using contrast-enhanced MR. AJNR 13 (1992), 5.
22. SCIALFA G., BELLONI G., DALLA PALMA L. et al.: Safety and efficacy of gadobenate dimeglumine (Gd-BOPTA/dimeg) in MRI of intracranial tumors. Neuroradiology 35 (Suppl.) (1993), 551.
23. TALLARIDA R. J. & MURRAY R. B.: Manual of pharmacologic calculations with computer programs. Springer, New York 1986.
24. -) in a mixture with its enantiomer. Inorg. Chem. 34 (1995), 633.
25. VITTADINI G., FELDER E., TIRONE P. & LORUSSO V.: B-19036, a potential new hepatobiliary contrast agent for MR proton imaging. Invest. Radiol. 23 (1988), S246.
26. VOGL T. J., PEGIOS W., MCMAHON C. et al.: Gadobenate dimeglumine, a new agent for MR imaging. Preliminary evaluation in healthy volunteers. AJR 158 (1992), 887.